<DOC>
	<DOC>NCT02559908</DOC>
	<brief_summary>This study will evaluate the safety and performance of VYC-25L hyaluronic acid injectable gel for the restoration and creation of facial volume in participants seeking to increase projection of the chin and/or jaw.</brief_summary>
	<brief_title>A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Has chin retrusion. Has ever received or is planning to receive permanent facial implants during the study. Has tattoos, piercings, facial hair or scars that would interfere with visual assessments of the chin or jaw. Has dentures or any device covering part of the palate or plans to undergo any dental procedure other than prophylaxis during the study. Has undergone semipermanent dermal filler treatment to the chin or jaw within 36 months or is planning treatment during the study. Has undergone any surgery of the chin or jaw area within 24 months or a planned surgery during the study. Has undergone mesotherapy, cosmetic resurfacing, or botulinum toxin injections within 6 months or a planned treatment during the study. Has experienced trauma to the chin and jaw area within 6 months. Has been previously diagnosed with streptococcal disease. Has a history of anaphylaxis or allergy to lidocaine, hyaluronic acid or streptococcal protein. Has porphyria or untreated epilepsy. Has active autoimmune disease. Has current cutaneous or mucosal inflammatory or infectious processes, abscess, an unhealed wound, or a cancerous or precancerous lesion. Is on a concurrent regimen of lidocaine or structurallyrelated local anesthetics or is on a concurrent regimen of drugs that reduce or inhibit hepatic metabolism. Has impaired cardiac conduction, severely impaired hepatic function, or severe renal dysfunction. Is on an ongoing regimen of anticoagulation therapy. Is on an ongoing regimen of medications (eg, aspirin, ibuprofen) or other substances known to increase coagulation time (eg, herbal supplements with garlic or gingko biloba) within the past 10 days. Has begun using any overthecounter or prescription oral or topical, antiwrinkle products below the subnasale within 30 days before enrollment or is planning to begin using such products during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>